Fed says it’s not ready to cut rates until ‘greater confidence’ inflation is moving to 2% goal
Federal Reserve officials at their June meeting indicated that inflation is moving in the right direction but not quickly enough ...
Tag: Breaking news
Crypto company Consensys sued by SEC as regulator continues industrywide crackdown
Joseph Lubin, co-founder of Ethereum and CEO of blockchain firm ConsenSys.Riccardo Savi | Getty Images for Concordia SummitCrypto firm Consensys ...
Apple Intelligence won’t launch in EU in 2024 due to antitrust regulation, company says
Tim Cook, chief executive officer of Apple Inc., during the Apple Worldwide Developers Conference at Apple Park campus in Cupertino, ...
Activist Starboard sues Autodesk in bid to mount proxy fight
Autodesk president and CEO Andrew Anagnost.AutodeskStarboard Value sued software maker Autodesk on Monday to delay the company's annual meeting and reopen ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom In IconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck's new vaccine ...
Activist Starboard amasses Autodesk stake, weighs suit over delayed probe disclosure
Jeffrey Smith, CEO and chief investment officer at Starboard Value LP.David Paul Morris | Bloomberg | Getty ImagesStarboard Value, the activist fund ...
Fed holds rates steady, indicates only one cut coming this year
The Federal Reserve on Wednesday kept its key interest rate unchanged and signaled that just one cut is expected before ...
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Empty bottles of Moderna's Covid-19 vaccine.Fred Tanneau | AFP | Getty ImagesModerna on Monday said its combination vaccine that targets ...
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday ...
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in ...
